Oral Webinar | Oral Cancer and Oral Diseases
8 Feb 2023, 09:00 (CET)
Oral Cancer, Oral Squamous Cell Carcinoma, Diagnosis, Diagnostic Delay, Oral Biopsy, Oral Surgery, Microbioma, Artificial Intelligence, AI
Welcome from the Chair
1st Oral Webinar
Oral Cancer and Oral Diseases
OSCC is one of the most prevalent cancers worldwide. Despite recent advances in diagnosis, surgical techniques, and adjuvant therapy, in the last years it has been registered an increase of the incidence of the OSCC and the mortality rate is still high.
The etiopathogenesis of OSCC is multifactorial, it has been related mainly to chemical factors, and to other factors, such as infections, and genetic alterations. Although the easy accessibility of the oral cavity, most cases of OSCC are diagnosed in advanced stages. Survival data is strongly influenced by the diagnostic delay, that refers to the time elapsing between the moment when the patient recognizes the first sign or symptoms of illness and the time when a definitive diagnosis is made, following a specialist examination.
To date, more than 50% of patients with OSCC are diagnosed at an advanced stage, and the 5-year survival rate of these patients is less than 50%. An early diagnosis of OSCC plays a crucial role in improving a patient's prognosis, as a five-year survival period is more than 90% if diagnosed early, falling to 5–20% for a late diagnosis.
The gold standard for OSCC diagnosis still is the incisional biopsy for histological confirmation. However, cancer research is currently focusing on finding less invasive and cost-effective methods to provide a more comprehensive view of the cancer profile, also to more easily monitor its evolution and therapeutic response. In this regard, many non-invasive techniques such as liquid biopsy have been recently proposed as supportive tools for diagnosis, prognosis, and follow-up of OSCC. Additionally, the relationship between human microbiota and carcinogenesis is a hot topic in cancer research.
The aim of this webinar is to discuss latest developments in the field of OSCC regarding the topics previously described.
Date: 8 February 2023
Time: 9:00 am CET | 3:00 am EST | 4:00 pm CST Asia
Webinar ID: 860 7732 4826
Webinar Secretariat: oral.webinar@mdpi.com
Chair
Department of Rehabilitation, Fragility and Continuity of Care, Unit of Oral Medicine, University Hospital Palermo, Palermo, Italy,
Counsellor of the National Board of SIPMO
Giuseppina Campisi born in Sciacca (AG, Italy) in 1965. She is Full Professor of Oral Pathology and Medicine, University of Palermo, and Head of Oral Medicine Unit, AOUP “Paolo Giaccone” of Palermo, where she manages different multidisciplinary projects: PRO.MO.G.E. (Prevention and Research on Oral Medicine, Gastroenterology and Hepatology – Member Unit), GOTEC (Head and Neck Oncology Management – Member Unit) and P.R.O.Ma.F (Prevention and Research of Medication-related Osteonecrosis of the jaws – Coordinator Unit). She is the past-dean of the Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.) of the University of Palermo (2018 - 2022). She has been member-coordinator of several academic institutions of University of Palermo (Vice-Dean of Department Coordinator of Experimental Oncology and Surgery International PhD courses, Academic Senate for Associates, University Scientific Committee). She is the responsible of the Oral Medicine Clinical Research Sector, where she conducts her research and clinical activities on Oral Pathology contexts, managing several oral screening programs (e.g. prevention and management of oral cancer and medication-related osteonecrosis of the jaws), projects aimed to improve oral health care management, also by teledentistry network, especially for medically-systemic complex patients, and numerous animal-human multicenter trials (e.g. on new diagnostic and drug testing oral devices). Moreover, of the research unit regarding the project “Network for oral medicine on frailty and oncologic patients” – Research project PSN 2013. She has authored over 200 scientific publications and attends as reviewer of the editorial board of several scientific journals. Currently, she is the scientific director of CINBO (National Inter-university Consortium for Bio-oncology), past-president of SIPMO (Italian Society of Oral Pathology and Medicine) and member of many scientific Societies in Oral and Maxillo-Facial fields.
Invited Speakers
Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, Palermo, Italy,
Active Member of SIPMO
Associate Professor University of Palermo. She has conducted for many year research and clinical activities on oral diseases (e.g. prevention and management of oral cancer and medication-related osteonecrosis of the jaws), projects aimed to improve oral health care management, also by teledentistry network and artificial intelligence (E- Health). She is teacher of Preliminary Oral pathology and Medicine Course and of Medical Technology for Dentistry in Palermo University (UNIPA). She is CEO of an academic spin off dedicate to integration of technology in Oral Medicine (e.g. implementation of mobile medical application as Doctoral). She is active member of the Italian Society of Oral Pathology and Medicine (SIPMO). She has authored over 100 scientific publications and attends as reviewer of the editorial board of several scientific journals.
Department of Surgical, Oncological, and Oral Sciences, University of Palermo, Palermo, Italy,
Active Member of SIPMO
Currently, he is a researcher of the Department of Oncological, Surgical and Stomatological Disciplines (DiChirOnS) of the University of Palermo (UNIPA, Italy - https://www.unipa.it/persone/docenti/m/rodolfo.mauceri/?pagina=curriculum). At the moment, his research concerns the study of oral microbiota in patients with oral carcinoma and the prevention and treatment of medication-related osteonecrosis of the jaw. He graduated in “Dentistry and Prosthetic dentistry” at the University of Palermo on 28th March 2011. He accomplished an International joint PhD Program in “Oncology and Experimental surgery” (Cycle XXIX - UNIPA and Universiteit Antwerpen, Belgium); during the PhD program he also achieved a fellowship program in Head-neck & Oral Oncology at the Universiteit Antwerpen. On December 2017 he attained a Master in "Oral Surgery" (II level) at the University Sapienza (Italy). On February 2022 he accomplished the Postgraduate School of Oral Surgery of the Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina (Italy). He is author/co-author of several scientific articles in international and national journals (scopus: https://www.scopus.com/authid/detail.uri?authorId=57195263668). He is active member of the Italian Society of Oral Pathology and Medicine (SIPMO); the Italian Society of Odontostomatological Surgery (SIdCO) and the Academy of Non Transfusional Hemo-Components (ANTHEC).
Department of Oral Sciences and Maxillofacial Surgery, Universita degli Studi di Roma La Sapienza, Rome, Italy,
Counsellor of the National Board of SIPMO
Full Professor in Oral Medicine and Pathology of Sapienza University of Rome. Elect Director of the Department of Oral Sciences and Maxillofacial Surgery. Specialist in Oral Surgery. Director of European Master Degree on Oral Laser applications (EMDOLA) of Sapienza University of Rome. Academic Coordinator for International Mobility Erasmus+ Faculty of Medicine and Dentistry. Vice President of SIPMO (Italian Society of Oral Pathology and Oral Medicine). Member of the Board of World Federation Laser in Dentistry (WFLD). PastPresident of Italian Society of Laser in Dentistry (SILO). He published several scientific articles in National and International journals.
Webinar Content
Program
Speaker/Presentation |
Time in CET |
Prof. Dr. Giuseppina Campisi Chair Introduction |
9:00 - 9:10 am |
Dr. Olga Di Fede Oscc Epidemiology, Risk Factors and Diagnostic Process |
9:10 - 9:30 am |
Dr. Rodolfo Mauceri Oral Microbiome and Biomarkers Associated to OSCC |
9:30 - 9:50 am |
Prof. Dr. Umberto Romeo Oral Biopsy: Types, Purpose, and Procedure |
9:50 - 10:10 am |
Q&A Session |
10:10 - 10:25 am |
Closing of Webinar |
10:25 - 10:30 am |